title: Molecular imaging can accelerate anti-angiogenic drug development and testing.
authors.affiliation: Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: Andrei
authors.initials: A
authors.lastname: Iagaru
authors.forename: Xiaoyuan
authors.initials: X
authors.lastname: Chen
authors.forename: Sanjiv Sam
authors.initials: SS
authors.lastname: Gambhir
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D008279:Magnetic Resonance Imaging; D009369:Neoplasms; D049268:Positron-Emission Tomography; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents